Is PHRM.CN undervalued or overvalued?
As of 2025-04-17, the Intrinsic Value of Newscope Capital Corporation (PHRM.CN) is -0.08 CAD. This PHRM.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.21 CAD, the upside of Newscope Capital Corporation is -140.54%. This means that PHRM.CN is overvalued by 140.54%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
Range | Selected | Upside | |
a | |||
Fair Value | -0.08 - -0.08 | -0.08 | -140.54% |
P/E | (0.01) - (0.11) | (0.01) | -106.9% |
DDM - Stable | (0.34) - 3.76 | 1.71 | 733.3% |
DDM - Multi | (0.41) - 3.45 | (0.92) | -547.2% |
Market Cap (mil) | 18.15 |
Beta | 0.93 |
Outstanding shares (mil) | 88.52 |
Enterprise Value (mil) | 16.66 |
Market risk premium | 5.10% |
Cost of Equity | 5.50% |
Cost of Debt | 5.00% |
WACC | 4.59% |